A New Heteroleptic Zn(II) Complex with Schiff Bases Sensitizes Triple-Negative Breast Cancer Cells to Doxorubicin and Paclitaxel.
Machado RADS, Siqueira RP, da Silva FC, Matos ACP, Borges DS, Rocha GG, Souza TCP, Souza RAC, Oliveira CR, Ferreira AG, Maia PIDS, Deflon VM, Oliveira CG, Araújo TG.
Machado RADS, et al. Among authors: oliveira cg, oliveira cr.
Pharmaceutics. 2024 Dec 18;16(12):1610. doi: 10.3390/pharmaceutics16121610.
Pharmaceutics. 2024.
PMID: 39771588
Free PMC article.